Henry Schein Inc. (HSIC)

MELVILLE, N.Y.--(BUSINESS WIRE)--For the 28th consecutive year, Henry Schein, Inc. (Nasdaq: HSIC) is helping students worldwide start the academic year off right through its “Back to School” program, ...

Henry Schein is transitioning to higher-margin businesses, with strong tailwinds in dental and medical markets, and is now fairly valued after previous overvaluation. KKR's strategic investment and re...

Henry Schein (HSIC) Q2 EPS Drops 11%

Henry Schein, Inc. (NASDAQ:HSIC ) Q2 2025 Earnings Conference Call August 5, 2025 8:00 AM ET Company Participants Graham Stanley - VP of Investor Relations & Strategic Finance Project Officer Ronald N...

The headline numbers for Henry Schein (HSIC) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street esti...

Henry Schein Inc. HSIC stock is trading lower on Tuesday after the company reported its second-quarter earnings.

HSIC slides after Q2 EPS misses estimates by 6.8%. Revenues beat with 3.2% growth and strength across key segments.

Henry Schein (HSIC) came out with quarterly earnings of $1.1 per share, missing the Zacks Consensus Estimate of $1.18 per share. This compares to earnings of $1.23 per share a year ago.

Henry Schein missed Wall Street estimates for second-quarter profit and maintained its annual forecast on Tuesday, due to softer demand for its dental products in the United States.

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today reported financial res...